Search

2 result(s) for 'author#Harukazu Hiraumi' within BMC

1. A randomized controlled clinical trial of topical insulin-like growth factor-1 therapy for sudden deafness refractory to systemic corticosteroid treatment

   To date, no therapeutic option has been established for sudden deafness refractory to systemic corticosteroids. This study aimed to examine the efficacy and safety of topical insulin-like growth factor-1 (IGF-...

   Authors: Takayuki Nakagawa, Kozo Kumakawa, Shin-ichi Usami, Naohito Hato, Keiji Tabuchi, Mariko Takahashi, Keizo Fujiwara, Akira Sasaki, Shizuo Komune, Tatsunori Sakamoto, Harukazu Hiraumi, Norio Yamamoto, Shiro Tanaka, Harue Tada, Michio Yamamoto, Atsushi Yonezawa…

   Citation: BMC Medicine 2014 12:219

   Content type: Research article Published on: 19 November 2014

   • View Full Text
   • View PDF

2. Topical insulin-like growth factor 1 treatment using gelatin hydrogels for glucocorticoid-resistant sudden sensorineural hearing loss: a prospective clinical trial

   Sudden sensorineural hearing loss (SSHL) is a common condition in which patients lose the hearing in one ear within 3 days. Systemic glucocorticoid treatments have been used as standard therapy for SSHL; howev...

   Authors: Takayuki Nakagawa, Tatsunori Sakamoto, Harukazu Hiraumi, Yayoi S Kikkawa, Norio Yamamoto, Kiyomi Hamaguchi, Kazuya Ono, Masaya Yamamoto, Yasuhiko Tabata, Satoshi Teramukai, Shiro Tanaka, Harue Tada, Rie Onodera, Atsushi Yonezawa, Ken-ichi Inui and Juichi Ito

   Citation: BMC Medicine 2010 8:76

   Content type: Research article Published on: 25 November 2010

   • View Full Text
   • View PDF